02738nam 2200589Ia 450 991082662050332120200520144314.01-282-76098-X978661276098392-9021-682-4(CKB)2670000000033937(EBL)538062(OCoLC)781625393(SSID)ssj0000422896(PQKBManifestationID)11271158(PQKBTitleCode)TC0000422896(PQKBWorkID)10432667(PQKB)10905482(MiAaPQ)EBC538062(Au-PeEL)EBL538062(CaPaEBR)ebr10392231(CaONFJC)MIL276098(EXLCZ)99267000000003393720090311d2009 uy 0engur|n|---|||||txtccrMeasuring transparency to improve good governance in the public pharmaceutical sectorJordan1st ed.Cairo, Egypt World Health Organization, Regional Office for the Eastern Mediterraneanc20091 online resource (70 p.)Description based upon print version of record.92-9021-649-2 Includes bibliographical references.COVER; TITLE; COPYRIGHT; Contents; Foreword; 7 Preface; Acknowledgements; Executive summary; 1. Introduction; 2. Overview of the public pharmaceutical sector in Jordan; 3. Methodology; 4. Results; 5. Data analysis and interpretation; 6. Recommendations; 7. Conclusions; AnnexesIn recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the goveJordanPharmaceutical industryStandardsJordanPharmaceutical policyJordanPharmaceutical industryStandardsPharmaceutical policy615.19World Health Organization.Regional Office for the Eastern Mediterranean.MiAaPQMiAaPQMiAaPQBOOK9910826620503321Measuring transparency to improve good governance in the public pharmaceutical sector3982904UNINA